Quantcast

Latest Inhalable insulin Stories

2014-07-16 20:22:30

LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Insulin Market Outlook 2018 https://www.reportbuyer.com/product/2080565/Global-Insulin-Market-Outlook-2018.html About 381 Million people suffered from diabetes in 2013 globally, which is likely to reach 591 Million by 2035. The growing number of diabetes patients at such a high pace significantly increases the demand for insulin products. The discovery of Insulin therapy has...

2014-07-03 12:25:46

NEW YORK, July 3, 2014 /PRNewswire/ -- MannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company focused on the discovery and development of therapeutic products for diseases such as diabetes. The company's lead product - Afrezza inhalation powder - was recently approved by the FDA as a rapid-acting insulin therapy intended to improve glycemic control in adults with type 1 or type 2 diabetes. MannKind was founded by Al Mann for the purpose of developing inhaled insulin as an...

Afrezza Inhalation Powder
2014-06-29 04:56:44

April Flowers for redOrbit.com - Your Universe Online Treatment options for diabetes come in a wide variety, ranging from oral medications to insulin pumps. USA Today reports that a new treatment option has been added to the arsenal, Afrezza Inhalation Powder. This week, the US Food and Drug Administration (FDA) approved the rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus, or Type I diabetes. The FDA estimates that 25.8 million people in...

2014-05-14 08:30:33

NEW YORK, May 14, 2014 /PRNewswire/ -- MannKind Corporation (NASDAQ: MNKD) In the U.S. alone, roughly 1 of 12 people are managing diabetes. China has approximately 100 million diabetic patients as of 2012 statistics. Total global insulin sales have grown an average of $4 billion a year between 2011 and 2012 ($16.8B in 2011 and $20.8B in 2012). However, in 2013, sharp price increases sent the total market up to $35 billion. By 2018, total insulin sales are expected to increase 66% to...

2013-10-04 23:00:35

ChinaMarketResearchReports.com adds Latest Report on “China Insulin Industry Report, 2012-2015” to its store. Dallas, TX (PRWEB) October 05, 2013 China is a country with the largest number of diabetics. In 2011, the market scale of diabetes medicine in China approximated RMB13.8 billion, of which, insulin medicines mainly comprising recombinant human insulin and insulin analog accounted for 52.8%. Due to high technological content and entry barriers, Chinese insulin market is...

Inhaled Insulin More Effective Than Injected, Oral Treatments
2013-08-15 05:18:19

redOrbit Staff & Wire Reports - Your Universe Online MannKind Corp. announced on Wednesday its inhaled insulin device was shown to be more effective than injected and oral treatments in two late-stage clinical trials. The product, known as Afrezza, consists of a fast-acting insulin powder delivered via MannKind’s lightweight inhaler. Administered at the start of a meal, Afrezza dissolves immediately upon inhalation and delivers insulin quickly to the blood stream. Peak insulin...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related